The bacteria are equipped with a gene that enables them to produce an enzyme that disables antibiotics. The enzyme is called Klebsiella pneumoniae carbapenamase, or KPC. It disables carbapenam antibiotics, last-ditch treatments for infections that don't respond to other drugs.
"We've lost our drug of last resort," Fishman says.
Doctors say the bacteria are more worrisome than another well-known superbug, methicillin-resistant Staphylococcus aureus (MRSA), because more drugs are available to treat MRSA, Fishman says. "When MRSA started to develop 15 years ago, the industry started producing antibiotics now coming onto the market," he says. "We're in the same position with KPCs as we were with staph aureus 15 years ago, except that the pharmaceutical industry isn't rushing to produce new drugs."
These strains of bacteria have been around for about a decade. Make no mistake though. The only way for these bacteria to have developed a resistance to this class of drugs is for them to have survived treatment by this class of drugs. Much like what I observed with Cipro, here in the US, after the attacks using Anthrax sent through the mail. Once the public learned about this new antibiotic, uncontrolled use of it soon followed.
There is no mechanism in medicine or government to control the use of new antibiotics. There used to be, but I think it has long since been abandoned, a victim of unlearned people screaming about class warfare and doing the work of the evil men who have been trying to destroy our civilization for the past 70 or so years. Now, because of the entrenched evil in our government, no program will succeed at keeping new drugs from being abused.
On a grander scale, this was forecast in Christan Prophesy about 1980 years ago.
No comments:
Post a Comment